[ANMCO Position paper: Evidence and practical indications for the use of low-dose rivaroxaban in stable coronary artery disease and peripheral artery disease].
Di Fusco SA, Rizzello V, Scicchitano P, Lucà F, Altamura V, Bianco M, De Luca L, Valente S, Riccio C, Caldarola P, Cipriani M, Francese GM, Navazio A, Nardi F, Ceravolo R, Gulizia MM, Gabrielli D, Oliva F, Colivicchi F.
Di Fusco SA, et al. Among authors: caldarola p.
G Ital Cardiol (Rome). 2022 Dec;23(12):967-976. doi: 10.1714/3913.38965.
G Ital Cardiol (Rome). 2022.
PMID: 36504216
Italian.